XEDITON Trademark

Trademark Overview


On Wednesday, March 5, 2008, a trademark application was filed for XEDITON with the United States Patent and Trademark Office. The USPTO has given the XEDITON trademark a serial number of 76687381. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Saturday, May 19, 2012. This trademark is owned by XEDITON PHARMACEUTICALS INC.. The XEDITON trademark is filed in the Pharmaceutical Products, Advertising and Business and Retail Services categories with the following description:

Vitamins, minerals, dietary supplements; pharmaceuticals, namely, pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the digestive system, endocrine system, integumentary system, lymphatic system, muscular system, nervous system, immune system, cardiovascular system, metabolic system, reproductive system, respiratory system, skeletal system, urinary system, and eyes; pharmaceuticals, namely, pharmaceutical preparations and substances for use in gastroenterology, oncology, ophthalmology, cardiology, dermatology, haematology, chemotherapy, psychiatry, urology, and neurology; pharmaceuticals, namely, pharmaceutical preparations and substances for the prevention and treatment of blood disorders, cancer, cardiovascular diseases, carpal tunnel syndrome, dental and oral diseases, headaches, pain, varicose veins, erectile dysfunction, gout, heart rhythm disorders, infectious diseases, gastro-intestinal diseases, diabetes, skin disorders, wo...

Providing consumer product information on pharmaceuticals, nutraceuticals, vitamins, minerals, dietary supplements, chemicals for medicinal purposes and medical devices and appliances
xediton

General Information


Serial Number76687381
Word MarkXEDITON
Filing DateWednesday, March 5, 2008
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateSaturday, May 19, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesVitamins, minerals, dietary supplements; pharmaceuticals, namely, pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the digestive system, endocrine system, integumentary system, lymphatic system, muscular system, nervous system, immune system, cardiovascular system, metabolic system, reproductive system, respiratory system, skeletal system, urinary system, and eyes; pharmaceuticals, namely, pharmaceutical preparations and substances for use in gastroenterology, oncology, ophthalmology, cardiology, dermatology, haematology, chemotherapy, psychiatry, urology, and neurology; pharmaceuticals, namely, pharmaceutical preparations and substances for the prevention and treatment of blood disorders, cancer, cardiovascular diseases, carpal tunnel syndrome, dental and oral diseases, headaches, pain, varicose veins, erectile dysfunction, gout, heart rhythm disorders, infectious diseases, gastro-intestinal diseases, diabetes, skin disorders, wounds, eye diseases and disorders, bacteria based diseases, inflamation, sepsis, alopecia, obesity, cognitive disorders, bone diseases, and viruses; pharmaceuticals, namely, pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, and inflammatory pelvic diseases; pharmaceuticals, namely, pharmaceutical preparations for the treatment of immunologic diseases, namely, auto-immune diseases and immunologic deficiency syndrome; pharmaceuticals, namely, pharmaceutical preparations for the treatment of infectious diseases, namely, respiratory infections, and eye infections; pharmaceuticals, namely, pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, and inflammatory connective tissue diseases; pharmaceuticals, namely, pharmaceutical preparations for the treatment of neurological diseases and disorders, namely, Alzheimer's, Huntington's Disease, cerebral palsy, brain injuries, spinal cord injuries, and seizures; pharmaceuticals, namely, pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, cognitive diseases, and schizophrenia; pharmaceuticals, namely, pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular mobility disorders, and spinal cord diseases; pharmaceuticals, namely, pharmaceutical preparations for the treatment of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, and Parkinson's disease; pharmaceuticals, namely, pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue disorders, bone diseases, spinal diseases, back pain, fractures, sprains, and cartilage injuries; pharmaceuticals, namely, pharmaceutical preparations for the treatment of viral diseases, namely, herpes, hepatitis, and Acquired Immune Deficiency Syndrome (AIDS); pharmaceuticals, namely, pharmaceutical preparations for the treatment of skin diseases and disorders, namely, dermatitis, skin pigmentation diseases, and sexually transmitted diseases; nutraceuticals, namely, vitamin, mineral and herbal food supplements; pharmaceuticals, namely, analgesics, muscle relaxants, antibacterial, anti-diabetics, antimicrobial preservatives, astringents, antitussive-cold preparations, anti-allergic preparations, anticoagulants antidepressants, appetite suppressants, vaccines, anti fungal preparations, antibiotics, anti-infective preparations, antiviral preparations, psychotropics, lipid lowering agents, anthelmintics, and skin lotions; nutraceuticals, namely, nutraceutical preparations and substances for the prevention and treatment of diseases and disorders of the digestive system, endocrine system, integumentary system, lymphatic system, muscular system, nervous system, immune system, cardiovascular system, metabolic system, reproductive system, respiratory system, skeletal system, urinary system, and eyes; nutraceuticals, namely, nutraceutical preparations and substances for use in gastroenterology, oncology, ophthalmology, cardiology, dermatology, haematology, chemotherapy, psychiatry, urology, and neurology; nutraceuticals, namely, nutraceutical preparations and substances for the prevention and treatment of blood disorders, cancer, cardiovascular diseases, carpal tunnel syndrome, dental and oral diseases, headaches, pain, varicose veins, erectile dysfunction, gout, heart rhythm disorders, infectious diseases, gastro-intestinal diseases, diabetes, skin disorders, wounds, eye diseases and disorders, bacteria based diseases, inflamation, sepsis, alopecia, obesity, cognitive disorders, bone diseases, and viruses; nutraceuticals, namely, nutraceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, and inflammatory pelvic diseases; nutraceuticals, namely, nutraceutical preparations for the treatment of immunologic diseases, namely, auto-immune diseases and immunologic deficiency syndrome; nutraceuticals, namely, nutraceutical preparations for the treatment of infectious diseases, namely, respiratory infections, and eye infections; nutraceuticals, namely, nutraceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, and inflammatory connective tissue diseases; nutraceuticals, namely, nutraceutical preparations for the treatment of neurological diseases and disorders, namely, Alzheimer's, Huntington's Disease, cerebral palsy, brain injuries, spinal cord injuries, and seizures; nutraceuticals, namely, nutraceutical preparations for the treatment of psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, cognitive diseases, and schizophrenia; nutraceuticals, namely, nutraceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular mobility disorders, and spinal cord diseases; nutraceuticals, namely, nutraceutical preparations for the treatment of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, and Parkinson's disease; nutraceuticals, namely, nutraceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue disorders, bone diseases, spinal diseases, back pain, fractures, sprains, and cartilage injuries; nutraceuticals, namely, nutraceutical preparations for the treatment of viral diseases, namely, herpes, hepatitis, and Acquired Immune Deficiency Syndrome (AIDS); nutraceuticals, namely, nutraceutical preparations for the treatment of skin diseases and disorders, namely, dermatitis, skin pigmentation diseases, and sexually transmitted diseases; nutraceuticals, namely, analgesics, muscle relaxants, antibacterial, anti-diabetics, antimicrobial preservatives, astringents, antitussive-cold preparations, anti-allergic preparations, anticoagulants, antidepressants, appetite suppressants, vaccines, anti fungal preparations, antibiotics, anti-infective preparations, antiviral preparations, psychotropics, lipid lowering agents, anthelmintics, and skin lotions; chemicals for medicinal purposes, namely, calcium, hydrogen, iodine, iron, sodium, super, zinc
Goods and ServicesProviding consumer product information on pharmaceuticals, nutraceuticals, vitamins, minerals, dietary supplements, chemicals for medicinal purposes and medical devices and appliances

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 11, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, January 7, 2009
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameXEDITON PHARMACEUTICALS INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMississauga, Ontario L5N1P7
CA

Trademark Events


Event DateEvent Description
Monday, May 21, 2012ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Saturday, May 19, 2012ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, October 19, 2011INQUIRY AS TO SUSPENSION MAILED
Tuesday, October 18, 2011SUSPENSION INQUIRY WRITTEN
Tuesday, October 11, 2011LIE CHECKED SUSP - TO ATTY FOR ACTION
Wednesday, July 20, 2011APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 20, 2011TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, April 11, 2011LETTER OF SUSPENSION MAILED
Friday, April 8, 2011SUSPENSION LETTER WRITTEN
Monday, April 4, 2011AMENDMENT FROM APPLICANT ENTERED
Monday, April 4, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 18, 2011ASSIGNED TO LIE
Thursday, March 17, 2011FAX RECEIVED
Monday, September 20, 2010INQUIRY AS TO SUSPENSION MAILED
Friday, September 17, 2010SUSPENSION INQUIRY WRITTEN
Monday, March 15, 2010LETTER OF SUSPENSION MAILED
Friday, March 12, 2010SUSPENSION LETTER WRITTEN
Wednesday, March 10, 2010AMENDMENT FROM APPLICANT ENTERED
Wednesday, March 10, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 8, 2010FAX RECEIVED
Tuesday, September 8, 2009INQUIRY AS TO SUSPENSION MAILED
Saturday, September 5, 2009SUSPENSION INQUIRY WRITTEN
Thursday, March 5, 2009LETTER OF SUSPENSION MAILED
Wednesday, March 4, 2009SUSPENSION LETTER WRITTEN
Wednesday, January 7, 2009AMENDMENT FROM APPLICANT ENTERED
Wednesday, January 7, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 7, 2009ASSIGNED TO LIE
Tuesday, December 23, 2008PAPER RECEIVED
Monday, June 23, 2008NON-FINAL ACTION MAILED
Monday, June 23, 2008NON-FINAL ACTION WRITTEN
Sunday, June 15, 2008ASSIGNED TO EXAMINER
Saturday, March 15, 2008APPLICATION FILING RECEIPT MAILED
Tuesday, March 11, 2008NEW APPLICATION ENTERED IN TRAM